In particular, a lack of information on C-peptide and antiglutamic acid decarboxylase antibodies resulted in difficulty in the diagnosis of T1DM; however, we used the prescription of insulin with a specific self-injection fee for T1DM, as this is strictly applied for T1DM. The gene discussed is INS; the disease is type 1 diabetes mellitus.